A cloning product that David A. Mead developed at the University of Wisconsin-Madison is generating about $40 million of annual revenue for California-based Invitrogen Corp.
Office of Strategic Communication
A cloning product that David A. Mead developed at the University of Wisconsin-Madison is generating about $40 million of annual revenue for California-based Invitrogen Corp.